Literature DB >> 15375572

Identification and characterization of human CXXC10 gene in silico.

Masuko Katoh1, Masaru Katoh.   

Abstract

CXXC4 gene encodes Dishevelled-binding protein, functioning as a negative regulator of WNT - beta-catenin signaling pathway. CXXC5, encoding CXXC finger (PHD domain) protein, is the paralog of CXXC4. CXXC6, MLL, DNMT1, ASXL1, ASXL2, and ASXL3 are cancer-associated genes belonging to the CXXC gene family. Here, we identified and characterized CXXC10 (CXXL4L or CXXC6L) gene by using bioinformatics. Complete coding sequence of human CXXC10 cDNA was determined by assembling AI438961 EST, AC073046.7 genome sequence, BX492895 EST, and MGC22014 5'-truncated cDNA. CXXC10 gene products derived from nucleotide positions 428-739 and 811-3624 were designated CXXC10-1 and CXXC10-2, respectively. CXXC10-1 (103 aa) was homologous to CXXC4 and CXXC6 within the CXXC domain. CXXC10-2 (937 aa) was homologous to CXXC6, and KIAA1546. Complete coding sequence of KIAA1546 cDNA was determined by assembling BF900449 EST, IMAGE3536481 partial cDNA, and KIAA1546 5'-truncated cDNA (AB046766.1). LCXH1 domain (codon 1-273 of CXXC10-2) and LCXH2 domain (codon 778-854 of CXXC10-2) were conserved among CXXC10-2, KIAA1546, and CXXC6. CXXC4 and KIAA1546 genes were closely linked in head to head manner with an interval of about 700 kb. CXXC10 locus at 2p13.1, CXXC4-KIAA1546 locus at 4q24, and CXXC6 locus at 10q21.3 were paralogous regions within the human genome. Because CXXC4 and KIAA1546 genes were located in the opposite direction, intragenetic inversion might be generated within the ancestral CXXC4-KIAA1546 locus during evolution. This is the first report on CXXC10 gene as well as on the CXXC10, CXXC4-KIAA1546, and CXXC6 paralogs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15375572

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.

Authors:  Myoung Shin Kim; Seung Kew Yoon; Frank Bollig; Jirouta Kitagaki; Wonhee Hur; Nathan J Whye; Yun-Ping Wu; Miguel N Rivera; Jik Young Park; Ho-Shik Kim; Karim Malik; Daphne W Bell; Christoph Englert; Alan O Perantoni; Sean Bong Lee
Journal:  J Biol Chem       Date:  2010-03-10       Impact factor: 5.157

2.  Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.

Authors:  Anna M Jankowska; Hadrian Szpurka; Ramon V Tiu; Hideki Makishima; Manuel Afable; Jungwon Huh; Christine L O'Keefe; Rebecca Ganetzky; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

3.  CXXC5 expression in prostate cancer: implications for cancer progression.

Authors:  Ines Benedetti; Angelo M De Marzo; Jan Geliebter; Niradiz Reyes
Journal:  Int J Exp Pathol       Date:  2017-08       Impact factor: 1.925

4.  Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1.

Authors:  Carina Frauer; Andrea Rottach; Daniela Meilinger; Sebastian Bultmann; Karin Fellinger; Stefan Hasenöder; Mengxi Wang; Weihua Qin; Johannes Söding; Fabio Spada; Heinrich Leonhardt
Journal:  PLoS One       Date:  2011-02-02       Impact factor: 3.240

Review 5.  Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.

Authors:  Véronique Gelsi-Boyer; Mandy Brecqueville; Raynier Devillier; Anne Murati; Marie-Joelle Mozziconacci; Daniel Birnbaum
Journal:  J Hematol Oncol       Date:  2012-03-21       Impact factor: 17.388

6.  CXXC5 mediates growth plate senescence and is a target for enhancement of longitudinal bone growth.

Authors:  Sehee Choi; Hyun-Yi Kim; Pu-Hyeon Cha; Seol Hwa Seo; Chulho Lee; Yejoo Choi; Wookjin Shin; Yunseok Heo; Gyoonhee Han; Weontae Lee; Kang-Yell Choi
Journal:  Life Sci Alliance       Date:  2019-04-10

7.  Intrinsic and extrinsic connections of Tet3 dioxygenase with CXXC zinc finger modules.

Authors:  Nan Liu; Mengxi Wang; Wen Deng; Christine S Schmidt; Weihua Qin; Heinrich Leonhardt; Fabio Spada
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.